Literature DB >> 1580128

Ultrasound-guided fine needle aspiration of retroperitoneal, abdominal and pelvic lymph nodes. Diagnostic reliability.

I A al-Mofleh1.   

Abstract

A retrospective analysis was done of 37 ultrasonically guided fine needle aspirations (US-FNAs) from retroperitoneal, abdominal and pelvic lymph nodes. The cytologic examination diagnosed 15 cases of malignant and 13 of tuberculous lymphadenopathy. The aspirate was normal in the remaining nine patients. On further workup of the last group, five patients turned out to have false-negative cytology. Of them, two had neoplasms, another two had tuberculosis, and one had sarcoidosis. The neoplastic disorders consisted of 7 lymphomas, 5 secondary carcinomas, 2 seminomas and 1 carcinoid tumor. The diagnostic specificity was 100% and the sensitivity 85%. Neither major nor minor complications were encountered in these patients. US-FNA is safe, highly specific and sensitive in diagnosing malignant and tuberculous lymphadenopathy.

Entities:  

Mesh:

Year:  1992        PMID: 1580128

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Clinical value of CT-guided needle biopsy for retroperitoneal lesions.

Authors:  Yuki Tomozawa; Yoshitaka Inaba; Hidekazu Yamaura; Yozo Sato; Mina Kato; Takaaki Kanamoto; Makoto Sakane
Journal:  Korean J Radiol       Date:  2011-04-26       Impact factor: 3.500

2.  Solitary intra-abdominal tuberculous lymphadenopathy mimicking duodenal GIST.

Authors:  You Sun Kim; Jeong Seop Moon; Jung Whan Lee; Il Kim; Soo Hyung Ryu; In Wook Paik
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

3.  Diagnosis by endoscopic ultrasound guided fine needle aspiration of tuberculous lymphadenitis involving the peripancreatic lymph nodes: a case report.

Authors:  Joseph-D Boujaoude; Khalil Honein; Cesar Yaghi; Claude Ghora; Gerard Abadjian; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.